School of Medicine
Showing 261-280 of 353 Results
-
Anita Tanniru Mohan MBBS PhD MBA
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioAnita Mohan MBBS PhD MBA is a Clinical Assistant Professor in the Division of Plastic and Reconstructive Surgery. Dr Mohan graduated medical school from Imperial College London together with a bachelors with honors in Management (BSc). After completing core surgery residency training in London in the United Kingdom, she completed a clinical fellowship in plastic surgery, hand surgery and burns in Cape Town, South Africa. This was followed by plastic surgery training in Cambridge, United Kingdom. During her plastic surgery training program, Dr Mohan was awarded the Royal College of Surgeons (England) Blond McIndoe research scholarship which she used to pursue a post-doctoral research fellowship at the Mayo Clinic, Rochester Minnesota. In this time Dr Mohan completed her PhD from the University of Cambridge (U.K.) on the study of perforator anatomy and physiology of the microcirculation in breast reconstruction, for which she received the Royal College of Surgeons of England Aris and Gale Lectureship. Dr Mohan also worked in the lab at Mayo Clinic in the study of nerve regeneration in facial allotransplantation. Dr Mohan then went on to complete an integrated plastic surgery residency at the Mayo Clinic, Rochester Minnesota. Dr Mohan also completed her Masters in Business Administration (MBA) from the University of Minnesota during her residency training. Dr Mohan completed advanced training in reconstructive microsurgery at Stanford University and studied medical innovation in the Stanford Biodesign program.
Dr Mohan has a joint appointment at the Veteran’s Affairs Hospital in Palo Alto and Stanford University campus. Dr Mohan’s specializes in general reconstructive surgery, microsurgery and super-microsurgery techniques. Dr Mohan currently performs a broad scope of plastic surgery procedures, gender affirming top surgery with nipple neurotization, breast and abdominal procedures following massive weight loss, abdominal wall reconstruction, microsurgery reconstruction following cancer and trauma, lymphedema/lipedema and skin cancer surgery.
Dr Mohan’s research interests include the study of microcirculation and lymphedema research, clinical outcomes projects and simulation training. -
Minal Moharir
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioI was born, raised, and trained in Nashik, India where I completed my formal Medical Education before moving to New York City where I completed my residency in Internal Medicine at New York Downtown Hospital in New York, NY. My interests are in preventative medicne, health and wellness, occupational and environmental safety. In Stanford's Occupational Health Department, I practice clinical occupational medicine while working toward identifying health and safety issues within our enviroment to prevent further injury and illness to our employees.
-
David G. Mohler, MD
Clinical Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsDr. Mohler is involved in gene expression in sarcomas, and innovative anatomy-preserving surgical management of low grade chondrosarcomas.
-
James M. Mok, MD
Clinical Associate Professor, Orthopaedic Surgery
BioDr. Mok is a board-certified, fellowship-trained spine surgeon with the Stanford Medicine Spine Center in Redwood City. He is also a clinical associate professor of medicine in the Department of Orthopaedic Surgery.
Dr. Mok diagnoses and treats a wide range of degenerative spine conditions, including disc herniations, spinal stenosis, myelopathy, and spondylolisthesis, as well as patients who have had previous spine surgery. He specializes in minimally invasive surgical techniques and strives to perform the least invasive procedures with the highest chances of success. His surgical specialties include minimally invasive microdiscectomy and laminectomy, minimally invasive spinal fusion, and artificial disc replacement.
Prior to Stanford, Dr. Mok worked as an orthopaedic spine surgeon with the NorthShore Orthopaedic and Spine Institute, the only dedicated orthopedic specialty hospital in the Chicago region. He was previously Associate Professor of Orthopaedic Surgery and Rehabilitation Medicine at the University of Chicago.
Dr. Mok served on active duty in the United States Army Medical Corps with the rank of Major. His military experience included deployment to the Iraq theater as an orthopaedic surgeon and spine surgery consultant.
Dr. Mok has published work in many leading journals in his field, including The Spine Journal, Spine, and Journal of Bone and Joint Surgery. He has presented to his peers at international, national, and regional meetings, including annual meetings of the North American Spine Society, the Society for Minimally Invasive Spine Surgery, and the American Association of Orthopaedic Surgeons.
Dr. Mok is a member of the American Academy of Orthopaedic Surgeons, the American Orthopaedic Association, the North American Spine Society, the Scoliosis Research Society, and the Society for Minimally Invasive Spine Surgery. -
Matteo Amitaba Mole'
Assistant Professor of Obstetrics and Gynecology (Reproductive & Stem Cell Biology)
Current Research and Scholarly InterestsThe research focus of our laboratory is centered on investigating the complex process of human embryo implantation. Due to the limited availability of suitable model systems and inability to directly observe this process in vivo, this has been traditionally referred to as the enigmatic stage of human embryonic development.
The successful implantation of an embryo is crucial for the establishment of a healthy pregnancy. During the transition between the first and second week of gestation, the human embryo must securely implant into the maternal uterus, initiating development of the placenta to receive necessary nutrients and oxygen for its growth until birth.
However, the process of implantation in humans is highly susceptible to failure, with a significant percentage of embryos unable to develop beyond this stage leading to early miscarriages. This clinically observed "implantation barrier" often requires patients to undergo numerous cycles of IVF treatment, with no guarantee of a successful pregnancy outcome.
The primary objective is to increase the understanding of maternal-embryo interactions initiated at implantation, with the goal of developing clinical interventions to address the high incidence of implantation failures underlying pre-clinical miscarriages. -
Hylton Molzof, PhD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Molzof is a Clinical Assistant Professor and Licensed Psychologist in the Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine. She specializes in the assessment and treatment of sleep disorders via behavioral sleep medicine interventions, including Cognitive Behavioral Therapy for Insomnia (CBT-I) and positive airway pressure (PAP) desensitization. She also utilizes evidence-based techniques to help patients better manage circadian rhythm disorders, such as delayed sleep-wake phase disorder and shift work sleep disorder. Inspired by her background in public health, she has a strong interest in quality improvement and program development projects aimed at enhancing the quality and accessibility of sleep and circadian medicine for the diverse patient population served by Stanford Sleep Medicine Center.
-
Arash Momeni, MD, FACS
Associate Professor of Surgery (Plastic and Reconstructive Surgery)
Current Research and Scholarly InterestsDr. Momeni's research focuses on clinical outcomes after microsurgical reconstruction, with a particular emphasis on VTE prevention.
-
Denise M. Monack
Martha Meier Weiland Professor in the School of Medicine
Current Research and Scholarly InterestsThe primary focus of my research is to understand the genetic and molecular mechanisms of intracellular bacterial pathogenesis. We use several model systems to study complex host-pathogen interactions in the gut and in immune cells such as macrophages and dendritic cells. Ultimately we would like to understand how Salmonella persists within certain hosts for years in the face of a robust immune response.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Maren Monsen, MD
Sr Research Scholar, Pediatrics - Center for Biomedical Ethics
Current Research and Scholarly InterestsMaren Monsen, MD has directed multiple documentary films that have been nominated for Emmy Awards, broadcast on PBS, translated into many languages for international broadcast, and used in 75% of medical schools across the country. Her films include The Revolutionary Optimists, Rare, Worlds Apart, Where the Highway Ends and The Vanishing Line. She is the founder and director the Program in Bioethics and Film at Stanford Center for Biomedical Ethics.
-
Brent Monseur, MD, ScM
Instructor, Obstetrics & Gynecology - Reproductive Endocrinology & Infertility
BioBrent Monseur, MD, ScM, FACOG (he/they) is a board certified obstetrician/gynecologist and the founding director of the LGBTQ+ Family Building Clinical Research Program at Stanford University School of Medicine. They are an Instructor in the Department of OBGYN and lead a highly specialized team dedicated to improving reproductive outcomes for sexual and gender minority populations. They completed a fellowship in Reproductive Endocrinology & Infertility at Stanford University after finishing an OB GYN Residency at Thomas Jefferson University. Dr. Monseur received a medical doctorate from the Medical College of Virginia. They trained as a reproductive biologist at the Johns Hopkins Bloomberg School of Public Health where they completed a Master of Science degree. Dr. Monseur received a Bachelor of Science degree in Biochemistry with a concentration in Spanish from the University of Mary Washington.
They have received numerous awards for their work with the LGBTQ+ community including the inaugural Stanford Graduate Medical Education Award for Promoting Health Equity, the Diversity Fellowship Research Award from the American Society for Reproductive Medicine, and an NIH Health Disparities Research Loan Repayment Program award. They serve as a chair of the American Society for Reproductive Medicine’s LGBTQ+ Special Interest Group and have previously served as a board member of two non-profit organizations dedicated to reproductive justice: Medical Students for Choice and Path2Parenthood (now Family Equality). -
Tamara Montacute, MD, MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioTamara Kailoa Montacute is a board certified Family Medicine physician. She enjoys taking care of the entire family (including kids), and has special interest in women’s health, adolescent health, community health, chronic disease management, mental health and office based procedures. She also speaks Spanish.
She was born in New Zealand, grew up in England and moved to Seattle when she was twelve. Prior to attending medical school at Stanford, she completed her Masters in Public Health at Columbia University and spent several years working on public health programs in Mexico, Panama, Ethiopia and Rwanda. After medical school, she completed a Family Medicine Residency at O’Connor Hospital in San Jose. She is the co-medical director of Arbor Free Clinic, teaches several primary care focused medical student courses and spends part of her time caring for patients at the Samaritan House Free Clinics in Redwood City and San Mateo.
Outside the clinic, she enjoys hiking, biking, gardening and playing with her daughter and 2 dogs. -
Artis A. Montague, MD, PhD
Clinical Professor, Ophthalmology
Current Research and Scholarly InterestsMulticenter Catalys Consortium Trial - To compare femtosecond laser assisted cataract surgery with conventional cataract surgery
-
Stephen B. Montgomery
Stanford Medicine Professor of Pathology, Professor of Genetics and of Biomedical Data Science
Current Research and Scholarly InterestsWe focus on understanding the effects of genome variation on cellular phenotypes and cellular modeling of disease through genomic approaches such as next generation RNA sequencing in combination with developing and utilizing state-of-the-art bioinformatics and statistical genetics approaches. See our website at http://montgomerylab.stanford.edu/
-
Thomas Montine, MD, PhD
Stanford Medicine Professor of Pathology
BioDr. Montine received his education at Columbia University (BA in Chemistry), the University of Rochester (PhD in Pharmacology), and McGill University (MD and CM). His postgraduate medical training was at Duke University, and he was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship in Pathology. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology and Director of the Division of Neuropathology at the University of Washington. He was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and passed that responsibility to able colleagues. Dr. Montine was the founding Director of the Pacific Udall Center, a NINDS-funded Morris K. Udall Centers of Excellence for Parkinson’s Disease Research. In 2010, Dr. Montine was appointed Chair of the Department of Pathology at the University of Washington. In 2016, Dr. Montine was appointed Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor in Pathology.
The focus of the Montine Laboratory is on the structural and molecular bases of cognitive impairment. The Montine Laboratory addresses this prevalent, unmet medical need through a combination of neuropathology, biomarkers for detection and progression of early disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and then develop novel approaches to neuroprotection. Our current approaches include small molecule precision therapeutics and cell replacement strategies for brain.
